Best indicator for assesment of tissue perfusion in a septic patient is?
lactate tissue perfusion sepsis indicator
| Lactate Level | Interpretation |
|---|---|
| < 2 mmol/L | Normal |
| 2-4 mmol/L | Cryptic shock / occult hypoperfusion - warrants aggressive resuscitation |
| > 4 mmol/L | Overt shock - high mortality, ICU admission mandatory |
| Marker | Role | Limitation vs Lactate |
|---|---|---|
| Serum lactate | Best overall tissue perfusion indicator | Affected by clearance issues |
| ScvO2 (central venous O2 sat) | Surrogate for O2 extraction ratio; >70% is a target | Mixed evidence for outcome benefit; newer trials failed to replicate early benefit |
| Blood pressure / MAP | Crude hemodynamic marker | Misses occult/cryptic shock |
| Urine output | Marker of renal perfusion | Lagging indicator |
| Procalcitonin | Infection/inflammation marker | Not a perfusion marker |
| Base deficit | Metabolic acidosis marker | Less specific than lactate |
What about the urine output? More than 0.5ml/kg/hr
| Marker | What it reflects | Speed | Specificity for global hypoperfusion |
|---|---|---|---|
| Serum lactate | Whole-body anaerobic metabolism | Fast (blood test) | Best - global |
| ScvO2 | Oxygen extraction across all tissue beds | Continuous (if CVC) | Good - global |
| Urine output >0.5 ml/kg/hr | Renal perfusion only | Hourly | Limited - organ-specific |
| MAP >65 mmHg | Driving pressure - not flow | Continuous | Poor - doesn't detect occult shock |
| Base deficit | Metabolic acidosis burden | Fast | Moderate |
Urine output is a resuscitation target (something you aim to achieve), while lactate is a perfusion indicator (something that directly tells you whether cells are getting enough oxygen). These are different roles.
Hematanesis patient resuscitation done with blood and fluids what is next step? Iv terlipression or binding?
variceal bleeding terlipressin band ligation management
esophageal varices acute bleeding treatment guidelines
PMID: 37978969
Resuscitation (blood + fluids)
↓
STEP 1: IV Vasoactive Drug IMMEDIATELY
(Start as soon as variceal source suspected - BEFORE endoscopy)
↓
STEP 2: Urgent Endoscopy (within 12 hours)
+ Endoscopic Band Ligation (EBL) ← preferred over sclerotherapy
↓
STEP 3: Continue vasoactive drug for 2-5 days post-endoscopy
(prevents early rebleeding)
↓
STEP 4: Early TIPS if high-risk (Child-Pugh B/C, HVPG >20 mmHg)
↓
STEP 5: Secondary prophylaxis with non-selective beta-blockers + repeat EBL
| Drug | Preferred in | Mechanism |
|---|---|---|
| Terlipressin | Europe, Asia, most of world | V1 receptor agonist - splanchnic vasoconstriction; also FDA-approved in USA since 2022 |
| Octreotide | USA (drug of choice per AGA 2024) | Somatostatin analog - inhibits splanchnic vasodilation |
| Somatostatin | Europe (where available) | Same as octreotide |
| Vasopressin | Largely abandoned | Too many cardiac side effects |
AGA 2024 Best Practice Advice 3: "Octreotide is the vasoactive drug of choice in the management of variceal hemorrhage based on its safety profile."
Terlipressin is equally effective but has more cardiac side effects (contraindicated in ischemic heart disease). In many exam contexts (Indian/UK boards), terlipressin is listed as the drug of choice.
| Your Question | Answer |
|---|---|
| IV Terlipressin or Band Ligation first? | Terlipressin (or octreotide) FIRST, then band ligation at endoscopy |
| Are they alternatives? | No - they are used together |
| Which is "the next step" after resuscitation? | IV vasoactive drug (terlipressin/octreotide) is the immediate next step |
Brain deaths criteria in icu
brain death determination criteria guidelines
PMID: 37821233
Definition: Irreversible cessation of all functions of the entire brain, including the brainstem, in a patient on mechanical ventilation with a known catastrophic brain injury.
| Prerequisite | Requirement |
|---|---|
| Known cause of coma | Confirmed by history + neuroimaging (CT/MRI) |
| Irreversibility established | Catastrophic structural brain injury; no treatable cause |
| Normothermia | Core temperature ≥36°C (hypothermia mimics brain death) |
| Hemodynamic stability | Systolic BP ≥100 mmHg (needed before apnea test) |
| No sedatives/analgesics | Adequate time for drug clearance; toxicology screen if uncertain |
| No neuromuscular blockers | Use peripheral nerve stimulator to confirm if any doubt |
| No severe metabolic derangement | Exclude severe electrolyte, acid-base, or endocrine abnormality |
| No hypoglycemia | Blood glucose must be normal |
| Neuroimaging explains coma | CT/MRI must show a lesion consistent with brain death |
| Reflex | How Tested | Expected in Brain Death |
|---|---|---|
| Pupillary light reflex | Bright light in each eye | Pupils fixed, mid-dilated (4-6 mm), no constriction |
| Corneal reflex | Cotton wisp on cornea | No blink response bilaterally |
| Oculocephalic reflex (Doll's eyes) | Head rotated rapidly side to side | Eyes remain fixed (no movement) - only test if C-spine cleared |
| Oculovestibular reflex (Caloric testing) | 50 mL ice water in each ear, head at 30°; wait 1 min, 5 min between sides | No eye deviation toward the cold stimulus |
| Gag reflex | Finger or tongue blade to posterior pharynx | Absent |
| Cough reflex | Deep suction catheter to level of carina | No cough response |
| Response to pain | Supraorbital/nail bed pressure | No grimacing, no purposeful movement |
Important: Constricted pupils suggest opioid effect - do NOT proceed until excluded.
| Test | Finding in Brain Death |
|---|---|
| EEG | Electrocerebral silence (flat, <2 mV for 30 min, min. 8 electrodes) |
| CT Angiography (head + neck) | No intracranial blood flow (gold standard for flow) |
| Nuclear CBF scan (Tc-99m) | No cerebral blood flow - "hollow skull sign" |
| Transcranial Doppler | Absent or reverberating flow pattern |
| Auditory/Somatosensory Evoked Potentials | Absent cortical responses |
BRAIN DEATH =
Known irreversible cause
+ No confounders (temp, drugs, metabolic)
+ Deep coma (no motor response)
+ All 7 brainstem reflexes absent
+ Positive apnea test (PaCO2 ≥60, no breathing)
| Feature | Brain Death | Vegetative State | Locked-in Syndrome |
|---|---|---|---|
| Brainstem reflexes | Absent | Present | Present |
| Apnea test | Positive | Breathes spontaneously | Breathes spontaneously |
| Eye movements | None | Roving | Vertical only |
| Awareness | None | None | Present |
| Legal death | Yes | No | No |
Patella surgery only one nerve block sufficient?
Patellar ORIF or tendon repair → Femoral nerve block (assuming a knee immobilizer will be used)
| Structure | Primary Nerve |
|---|---|
| Patella (bone + anterior capsule) | Femoral nerve (dominant) |
| Medial knee skin | Saphenous nerve (terminal branch of femoral) |
| Posterior knee | Sciatic/tibial/common peroneal |
| Medial capsule | Obturator nerve |
"Level 1 evidence in the setting of surgery for patella fractures suggests that fascia iliaca nerve blockade is equally efficacious while being safer and easier to perform relative to femoral nerve block."
| Block | Advantage |
|---|---|
| Femoral nerve block | Direct, well-established |
| Fascia iliaca block | Level 1 evidence; safer, easier; covers femoral + lateral femoral cutaneous + obturator nerves |
Most common nerve danaged in upper limb in type 2 crps
"Causalgia is the name that Weir Mitchell applied to peripheral neuralgia consequent on trauma, most often following partial interruption of the median or ulnar nerve and, less often, the sciatic or peroneal nerve."
| Feature | CRPS Type 1 (RSD) | CRPS Type 2 (Causalgia) |
|---|---|---|
| Nerve injury identifiable? | No - no specific nerve injury | Yes - direct, documented nerve injury |
| Former name | Reflex Sympathetic Dystrophy | Causalgia |
| Most common nerve (UL) | N/A | Median > Ulnar |
| Most common nerve (LL) | N/A | Sciatic > Peroneal |
| Mechanism | Unclear, possibly central sensitization | Partial nerve injury → sympathetic-afferent coupling |
"CRPS 2 = Causalgia = Median nerve most common in upper limb" (Weir Mitchell, Civil War wounds, burning pain in the hand)
Stepwise management plan for crps
complex regional pain syndrome treatment guidelines
PMID: 37185896
Core principle: Early, aggressive, multidisciplinary treatment gives the best outcomes. The longer CRPS is untreated, the more refractory it becomes. Physical rehabilitation is the backbone - everything else supports it.
| Modality | Details |
|---|---|
| Graded motor imagery (GMI) | Mirror therapy, mental imagery, left/right discrimination - targets cortical reorganization |
| Mirror therapy | Especially effective in early CRPS of upper limb |
| Desensitization | Progressive tactile stimulation to reduce allodynia |
| Active range of motion | Gentle, pain-guided mobilization; avoid forced movement |
| Edema management | Compression, elevation, contrast baths |
| Occupational therapy | Functional task retraining, splinting, adaptive equipment |
"A certain degree of improvement can be expected if treatment is started early and the limb is mobilized." - Adams & Victor's Neurology, 12e
| Drug | Dose | Notes |
|---|---|---|
| Gabapentin | 300-3600 mg/day | First-line neuropathic agent |
| Pregabalin | 150-600 mg/day | Alternative to gabapentin |
| TCAs (amitriptyline, nortriptyline) | 10-75 mg at night | Also treats depression/sleep |
| SNRIs (duloxetine) | 30-120 mg/day | Good for sympathetically maintained pain |
| Drug | Evidence |
|---|---|
| Bisphosphonates (IV pamidronate, alendronate) | Strong evidence - reduces pain and bone resorption in CRPS |
| Calcitonin (intranasal) | Reduces bone pain; less used now |
| Corticosteroids (prednisolone 30-80 mg/day, short course) | Useful in early, hot/inflammatory CRPS |
| NSAIDs | Mild benefit only |
| Drug | Mechanism | Evidence |
|---|---|---|
| IV Ketamine (low-dose infusion) | NMDA antagonist - resets central sensitization | Strong evidence; used in refractory cases |
| IV Lidocaine | Membrane stabilization | Good evidence per 2023 systematic review [PMID: 37185896] |
| Opioids | Last resort; limited evidence; risk of dependence | Use cautiously |
| Clonidine (oral/patch/epidural) | α2-agonist - reduces sympathetic outflow | Useful adjunct |
| Block | Upper Limb | Lower Limb |
|---|---|---|
| Stellate ganglion block | Yes - T1 sympathetics | No |
| Lumbar sympathetic block | No | Yes |
| Mechanism: Local anesthetic (procaine/bupivacaine) → interrupts sympathetic-afferent loop |
"It can respond favorably, if only temporarily, to procaine block of the appropriate sympathetic ganglia." - Adams & Victor's Neurology, 12e
DIAGNOSIS (Budapest Criteria)
↓
STEP 1: Physiotherapy + Graded Motor Imagery (START EARLY)
↓
STEP 2: Pharmacotherapy
- Gabapentin/TCAs/SNRIs
- Bisphosphonates
- Topical lidocaine/DMSO
- Steroids (if early/hot phase)
+ Psychological support (CBT)
↓
STEP 3: Sympathetic nerve blocks
(Stellate - upper limb | Lumbar - lower limb)
+ Brachial plexus block / IV guanethidine
+ IV Ketamine / IV Lidocaine infusion
↓
STEP 4: Spinal Cord Stimulation (SCS)
↓
STEP 5: Surgical sympathectomy (last resort)
| Fact | Answer |
|---|---|
| Foundation of CRPS treatment | Physiotherapy (especially graded motor imagery) |
| Strongest evidence drug class | Bisphosphonates + IV Ketamine + IV Lidocaine |
| Sympathetic block for upper limb | Stellate ganglion block |
| Best long-term interventional option | Spinal cord stimulation |
| Vitamin C for prevention? | No - 2023 systematic review shows no significant benefit [PMID: 37185896] |
| Key principle | Multidisciplinary + Early |
| Pathway | Structure | Function |
|---|---|---|
| Spinothalamic tract (neospinothalamic) | Spinal cord → VPL thalamus → Somatosensory cortex (S1/S2) | Sensory-discriminative aspect: WHERE does it hurt? HOW intense? |
| Spinoparabrachial tract (paleospinothalamic) | Spinal cord → Parabrachial nucleus → Limbic system (amygdala, anterior cingulate, insular cortex) | Affective-motivational aspect: HOW unpleasant? Emotional suffering, memory of pain |
"Sensory discriminative features of the pain experience are transmitted from the spinal cord to the ventroposterolateral thalamus via the spinothalamic tract. A second pathway (the spinoparabrachial tract) carries information from the spinal cord to the parabrachial nucleus of the dorsolateral pons. These neurons in turn target limbic forebrain regions, including the insular and anterior cingulate cortex, which process emotional features of the pain experience." - Kandel's Principles of Neural Science, 6e
| Option | Role in Pain | Why NOT the answer |
|---|---|---|
| A. Medial Thalamus | Arousal, attention, affective tone of pain | Relay station only - not the primary memory/emotion processor |
| B. Lateral Thalamus (VPL) | Sensory-discriminative - location, intensity, quality | Processes "where/how much," NOT emotion or memory |
| C. Reticular Formation | Arousal, modulation of pain via descending pathways | Does not process memory or emotional response |
| D. VPL Nucleus | Same as lateral thalamus - somatosensory relay | Precision of pain location, not emotional memory |
| E. Limbic System (Amygdala/Hippocampus) ✓ | Emotional response (amygdala = fear/aversion) + Memory (hippocampus = contextual memory of painful events) | Correct answer |
Medial thalmus?
"Many neurons in the medial thalamus respond optimally to noxious stimuli and project to many regions of the limbic system, including the anterior cingulate cortex."
Spinal cord
↓
Paleospinothalamic tract
↓
MEDIAL THALAMUS ──────────────→ LIMBIC SYSTEM
(relay/transmitter) (Amygdala + Hippocampus)
↑ THIS is where emotional
processing and MEMORY
of pain actually happen
| Structure | Role | Analogy |
|---|---|---|
| Medial Thalamus | Relay station - passes pain signals toward limbic regions; contributes to affective tone and arousal | A postal sorting office |
| Limbic System (Amygdala/Hippocampus) | Final processor of emotional response + memory encoding of pain | The person who reads and reacts to the letter |
| Structure | Sensory Location | Intensity | Affective Tone | Emotional Response | Memory of Pain |
|---|---|---|---|---|---|
| VPL (Lateral Thalamus) | ✓✓ | ✓✓ | ✗ | ✗ | ✗ |
| Medial Thalamus | ✗ | ✗ | ✓ (relay) | ✗ (projects to limbic) | ✗ |
| Limbic System (Amygdala/Hippocampus) | ✗ | ✗ | ✓✓ | ✓✓ | ✓✓ |
| Anterior Cingulate Cortex | ✗ | ✗ | ✓✓ | ✓✓ | ✗ |
Please explain hand nerve supply with images nerves involved snd clinical scebarios

| Nerve | Palm | Dorsum |
|---|---|---|
| Median | Lateral 3½ fingers (thumb, index, middle, radial half of ring) + thenar skin | Distal dorsum of index, middle, radial ring finger (fingertip skin) |
| Ulnar | Medial 1½ fingers (ulnar half of ring + little finger) | Medial dorsum of hand + little finger (exclusive territory) |
| Radial | Virtually NONE (small thenar skin strip) | Dorsum of hand, thumb, index, middle finger (proximal - to PIP level) |
Important: The dorsal fingertips of index, middle, and ring fingers are supplied by the median nerve via dorsal branches of palmar digital nerves - NOT by the radial nerve. This is a classic exam trap.
| Muscle | Function |
|---|---|
| Lumbricals 1 & 2 (radial two) | Flex MCP, extend IP joints of index & middle finger |
| Opponens pollicis | Opposition of thumb (most important!) |
| Abductor pollicis brevis | Abducts thumb |
| Flexor pollicis brevis (superficial head) | Flexes thumb MCP |
Note: "Hand of benediction" = injury ABOVE wrist. "Ape hand" (thenar wasting only) = injury AT wrist (CTS chronic).
| Group | Muscles |
|---|---|
| Hypothenar muscles | Abductor digiti minimi, flexor digiti minimi, opponens digiti minimi |
| Lumbricals 3 & 4 (ulnar two) | Ring and little finger MCP flexion, IP extension |
| All interossei (7 total) | PAD = Palmar Adduct, DAB = Dorsal ABduct |
| Adductor pollicis | Adducts thumb (key for grip) |
| Flexor pollicis brevis (deep head) | Flexes thumb |
| Palmaris brevis | Wrinkles hypothenar skin |
"Ulnar nerve palsy is the most common peripheral nerve paralysis. The characteristic feature is a 'claw hand' deformity, in which loss of the interosseous muscles causes the fingers to be hyperextended at the MCPs and slightly flexed at the PIPs/DIPs."

Paradox of clawing: High ulnar nerve lesion (at elbow) = LESS clawing than low lesion (at wrist). Because at elbow, FDP to ring and little finger is also lost - so fingers can't flex into a claw. At wrist, FDP is intact, making the claw more pronounced. This is Ulnar Paradox.
| Feature | At Elbow | At Wrist (Guyon's Canal) |
|---|---|---|
| Claw hand | Less pronounced | More pronounced (Ulnar paradox) |
| Hypothenar sensation | Lost | Spared (palmar cutaneous branch exits proximal to canal) |
| FCU weakness | Yes | No |
| FDP ring/little weakness | Yes | No |
"When the radial nerve is damaged, the patient can no longer actively extend the hand at the wrist - wrist drop (drop hand) is present. Sensory loss on the radial surface of the dorsum and on the extensor surface of the thumb, index finger, and the radial half of the middle finger extending to the PIP joint."
| Site | Cause | Features |
|---|---|---|
| Axilla | Crutch palsy, axillary fracture | Triceps + wrist drop |
| Spiral groove | Midshaft humerus fracture, Saturday night palsy | Wrist drop, triceps SPARED |
| Lateral epicondyle (PIN) | Posterior interosseous nerve entrapment | Finger drop, wrist extensors SPARED |
| Wrist (superficial radial) | Handcuff neuropathy, de Quervain surgery | Sensory only - 1st web space |
| Feature | Median | Ulnar | Radial |
|---|---|---|---|
| Root values | C6-T1 | C8-T1 | C5-C8 |
| Thenar muscles | Yes (LOAF) | Only FPB deep head | No |
| Hypothenar muscles | No | Yes | No |
| Interossei | No | Yes (all 7) | No |
| Intrinsic hand motor | Partial | Most | None |
| Thumb opposition | Median | - | - |
| Thumb adduction | - | Ulnar | - |
| Wrist extension | No | No | Radial |
| Sensory (palm) | Lateral 3½ fingers | Medial 1½ fingers | Minimal |
| Sensory (dorsum) | Fingertips of 3½ | Medial dorsum | Radial dorsum (proximal) |
| Classic deformity | Ape hand / Benediction | Claw hand | Wrist drop |
| Common entrapment | Carpal tunnel | Cubital tunnel | Spiral groove |
| Special test | Tinel's, Phalen's | Froment's sign | - |
Neve suppy of hand with images illustrations clinical pearls of nerve damge entrapment





| Level of Injury | Clawing Severity | Why |
|---|---|---|
| High (elbow) | Less clawing | FDP to ring/little also paralyzed - no flexor to pull IPs into flexion |
| Low (wrist) | More clawing | FDP intact, acts unopposed on now-unbalanced fingers |
"The higher the ulnar nerve lesion, the less the claw" - this is paradoxical because you'd expect more damage = worse deformity.

| Feature | Cubital Tunnel (Elbow) | Guyon's Canal (Wrist) |
|---|---|---|
| FCU weakness | Yes | No |
| FDP (ring/little) | Weak | Normal |
| Hypothenar sensation | Lost | Spared (palmar branch exits before canal) |
| Dorsal ulnar sensation | Lost | Spared (dorsal branch exits before wrist) |
| Clawing | Less (Ulnar paradox) | More |
| Causes | Leaning on elbow, cubitus valgus, fracture | Hook of hamate fracture, cyclist's palsy, ganglion |


| Level of Injury | Cause | Triceps | Wrist Extension | Finger Extension | Sensory Loss |
|---|---|---|---|---|---|
| Axilla | Crutch palsy, axillary fracture | Paralysed | Lost | Lost | Posterior arm + dorsum |
| Spiral groove (mid-humerus) | Saturday night palsy, midshaft # humerus | Spared | Lost | Lost | Dorsum of hand |
| Lateral epicondyle (PIN) | Radial tunnel, head of radius fracture | Spared | Spared (ECRL) | Lost (finger drop) | None or minimal |
| Wrist (superficial branch) | Handcuffs, tight watch, de Quervain surgery | Spared | Spared | Spared | 1st web space only |

| Nerve | Injury | Deformity | Sensory Loss | Key Test |
|---|---|---|---|---|
| Median - high | Elbow/supracondylar # | Hand of benediction | Lateral 3½ palm | Bottle sign |
| Median - low | Carpal tunnel | Ape hand (thenar wasting) | Lateral 3½ fingers (thenar skin SPARED) | Tinel's, Phalen's |
| Median - AIN | Forearm | No deformity at rest | None | Failed OK sign |
| Ulnar - high | Cubital tunnel (elbow) | Mild claw (ring+little) | Medial 1½ + dorsal medial | Froment's |
| Ulnar - low | Guyon's canal (wrist) | Severe claw (ulnar paradox) | Medial 1½ fingers only (dorsal SPARED) | Froment's |
| Radial - axilla | Crutch palsy | Wrist drop + triceps weak | Posterior arm + dorsum | - |
| Radial - spiral groove | Saturday night palsy | Wrist drop, triceps OK | Dorsum of hand | - |
| Radial - PIN | Radial tunnel | Finger drop, NO wrist drop | None | - |
| Radial - wrist | Handcuff neuropathy | None | 1st dorsal web space only | - |
What is costochondritis vs tietze syndrome
"Tietze syndrome is manifested by painful swelling of one or more costochondral articulations... The term costochondritis is often used interchangeably with Tietze syndrome, but some authors restrict the latter term to pain of the costochondral articulations with swelling."
| Feature | Tietze Syndrome | Costochondritis |
|---|---|---|
| Key distinguishing feature | Swelling at costochondral junction ✓ | No swelling |
| Age of onset | <40 years | >40 years |
| Sex | Equal (M = F) | More common in women |
| Joints affected | Usually 1 joint (2nd or 3rd CJ most common) | Multiple joints - 3rd, 4th, 5th most common |
| Tenderness | Present | Present |
| Radiation | To arm/shoulder | To arm/shoulder |
| Aggravating factors | Coughing, sneezing, deep breath, twisting | Same |
| Nature | Benign, self-limiting | Benign, self-limiting |
| Treatment | NSAIDs, local steroid injection | NSAIDs, local steroid injection |
The ONE-LINE distinction for exams:
- Tietze = Tenderness + SWELLING (the "TE" in TiETze = Think Edema/swelling)
- Costochondritis = Tenderness ONLY, no swelling
| Condition | How to distinguish |
|---|---|
| MI | ECG changes, troponin rise, radiation to jaw/left arm, diaphoresis |
| Pleurisy | Pleural rub on auscultation, worsened by breathing, not by palpation |
| Intercostal muscle spasm | Pain along rib, not specifically at costochondral junction |
| Herpes zoster | Dermatomal rash, burning pain before vesicles |
| Xiphoidalgia | Pain at xiphoid process only |
| Slipping rib syndrome | Ribs 9-10, pain reproduced by hooking fingers under rib and pulling caudally |
| Malignancy | Weight loss, persistent, worsening, no response to NSAIDs |
Costochindritis vs tietz sy dromw
TIETZE = Pain + SWELLING at costochondral junction
COSTO = Pain ONLY, NO swelling
| Feature | Tietze Syndrome | Costochondritis |
|---|---|---|
| Swelling | YES (defining feature) | NO |
| Age | < 40 years | > 40 years |
| Sex | M = F (equal) | More in women |
| Joints | Usually 1 joint (2nd/3rd) | Multiple (3rd, 4th, 5th) |
| Tenderness | Yes | Yes |
| Radiation | Arm/shoulder | Arm/shoulder |
| Precipitants | Coughing, trauma, post-infection | Repetitive movements |
| Treatment | NSAIDs + local steroid injection | NSAIDs + local steroid injection |
🔑 "TiETzE" = Think Edema (swELLing)
🔑 "CoSTo" = Cost-no-swelling (no extra feature)
🔑 Tietze is YOUNGER, FEWER joints, HAS swelling
🔑 Costochondritis is OLDER, MORE joints, NO swelling
| Concentration | Meaning | mg per mL | Use |
|---|---|---|---|
| 1:1,000 | 1 g in 1,000 mL | 1 mg/mL | IM for anaphylaxis |
| 1:10,000 | 1 g in 10,000 mL | 0.1 mg/mL | IV cardiac arrest |
| 1:100,000 | 1 g in 100,000 mL | 0.01 mg/mL | Local anesthesia additive |
| Option | Problem |
|---|---|
| A: 0.01 mL/kg of 1:1000 | = 0.01 mcg/kg - 100x underdose |
| B: 0.1 mL/kg of 1:10,000 ✓ | = 10 mcg/kg = correct PALS dose |
| C: 0.1 mL/kg of 1:100,000 | = 1 mcg/kg - 10x underdose |
| D: 0.01 mL/kg of 1:10,000 | = 1 mcg/kg - 10x underdose |
| E: 1 mL/kg of 1:1000 | = 1 mg/kg - 100x overdose - DANGEROUS |
| Scenario | Dose | Concentration | Volume |
|---|---|---|---|
| Pediatric cardiac arrest (PALS) | 0.01 mg/kg (10 mcg/kg) IV | 1:10,000 | 0.1 mL/kg |
| Adult cardiac arrest (ACLS) | 1 mg flat dose IV | 1:10,000 | 10 mL |
| Pediatric ET tube (if no IV) | 0.1 mg/kg | 1:1,000 | 0.1 mL/kg |
| Anaphylaxis (IM) | 0.01 mg/kg (max 0.5 mg) | 1:1,000 | 0.01 mL/kg |
"For IV cardiac arrest in children: 0.1 mL/kg of 1:10,000"Both numbers start with 0.1 - easy to remember together
No its 1 mcg/kg
PALS epinephrine dose pediatric cardiac arrest IV mcg/kg 2024 guidelines
"Epinephrine IV/IO dose: 0.01 mg/kg (0.1 mL/kg of the 0.1 mg/mL concentration). Max dose 1 mg. Repeat every 3-5 minutes."
| Value | Unit | Same dose? |
|---|---|---|
| 0.01 mg/kg | mg | ✓ |
| 10 mcg/kg | mcg | ✓ Same thing |
| 1 mcg/kg | mcg | ✗ This is 10x less - underdose |
| Use | Dose | Route |
|---|---|---|
| Epinephrine infusion (vasopressor/inotrope in shock) | 0.1-1 mcg/kg/min (infusion) | IV drip |
| Bradycardia with pulse (not arrest) | 0.01 mg/kg (same as arrest) | IV |
| Anaphylaxis (IM) | 0.01 mg/kg = 10 mcg/kg | IM |
| Scenario | Correct Dose |
|---|---|
| Pediatric cardiac ARREST (IV/IO) | 0.01 mg/kg = 10 mcg/kg |
| Pediatric cardiac arrest (via ET tube) | 0.1 mg/kg = 100 mcg/kg |
| Epinephrine infusion for shock | 0.1-1 mcg/kg/min (continuous) |
| Adult cardiac arrest | 1 mg flat dose |
Sorry my bad i read anaphylaxis
| Scenario | Dose | Route | Concentration |
|---|---|---|---|
| Cardiac Arrest (PALS) | 0.01 mg/kg = 10 mcg/kg | IV/IO | 1:10,000 (0.1 mg/mL) → 0.1 mL/kg |
| Anaphylaxis (pediatric) | 0.01 mg/kg = 10 mcg/kg (max 0.5 mg) | IM (thigh) | 1:1,000 (1 mg/mL) → 0.01 mL/kg |
| Anaphylaxis infusion (refractory) | 0.1-1 mcg/kg/min | IV infusion | Diluted |
| ET tube (no IV access) | 0.1 mg/kg = 100 mcg/kg | Endotracheal | 1:1,000 |
The DOSE is the same for arrest and anaphylaxis (0.01 mg/kg) - but the ROUTE and CONCENTRATION differ:
- Arrest → IV, using 1:10,000
- Anaphylaxis → IM, using 1:1,000